Virulence factors and infection ability of Pseudomonas aeruginosa isolates from a hydropathic facility and respiratory infections

Journal of Applied Microbiology

Volumn 116, Issue 5, 2014, Pages 1359-1368

  Pereira, S G ^a   Rosa, A C ^b   Ferreira, A S ^c   Moreira, L M ^c   Proenca D N ^d   Morais, P V ^b,d   Cardoso, O ^a  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c Instituto de Biotecnologia e Bioengenharia Lisboa   (Portugal)

^d UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

Infection control; Pneumonia; Pseudomonas aeruginosa; Respiratory infections; Surveillance; Waterborne infections

Indexed keywords

BACTERIA; BEVERAGES; ELECTROPHORESIS; GENES; POLYMERASE CHAIN REACTION; WATER;

CONDITION; INFECTION CONTROL; MINERAL WATER; NATURAL MINERALS; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATORY INFECTION; SURVEILLANCE; VIRULENCE FACTORS; WATER BORNE INFECTIONS;

HEALTH RISKS;

MINERAL WATER; VIRULENCE FACTOR;

BACTERIAL DISEASE; ELECTROKINESIS; GENETIC ANALYSIS; HEALTH RISK; INFECTIOUS DISEASE; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; REGULATORY APPROACH; RESPIRATORY DISEASE; VIRULENCE;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOFILM; GALLERIA MELLONELLA; GENETIC ASSOCIATION; GENETIC VARIABILITY; NONHUMAN; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; RESPIRATORY TRACT INFECTION; WATER SUPPLY; ANIMAL; EUROPE; GENETICS; HEALTH CARE FACILITY; HUMAN; HYDROTHERAPY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOTH; PATHOGENICITY; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS;

EUROPE;

GALLERIA MELLONELLA; PSEUDOMONAS AERUGINOSA;

ANIMALS; BIOFILMS; EUROPE; HEALTH FACILITIES; HUMANS; HYDROTHERAPY; MOTHS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY TRACT INFECTIONS; VIRULENCE FACTORS;

EID: 84898483699     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.12463     Document Type: Article

References (30)

1. Allewelt, M., Coleman, F.T., Grout, M., Priebe, G.P. and Pier, G.B. (2000) Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread. Infect Immun 68, 3998-4004.
2. Arancibia, F., Bauer, T.T., Ewig, S., Mensa, J., Gonzalez, J. and Niederman, M.S. (2002) Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk and prognosis. Arch Intern Med 162, 1849-1858.
3. Battle, S.E., Rello, J. and Hauser, A.R. (2009) Genomic islands in Pseudomonas aeruginosa. FEMS Microbiol Lett 290, 70-78.
4. Bornstein, N., Marmet, D., Surgot, M., Nowicki, M., Arslan, A., Esteve, J. and Fleurette, J. (1989) Exposure to Legionellaceae at a hot spring thermae: a prospective clinical and serological study. Epidemiol Infect 102, 31-36.
5. Bradbury, R.S., Roddam, L.F., Merritt, A., Reid, D.W. and Champion, A.C. (2010) Virulence gene distribution in clinical, nosocomial and environmental isolates of Pseudomonas aeruginosa. J Med Microbiol 59, 881-890.
6. Chemani, C., Imberty, A., de Bentzmann, S., Pierre, M., Wimmerová, M., Guery, B.P. and Faure, K. (2009) Role of LecA and LecB lectins in Pseudomonas aeruginosa-induced lung injury and effect of carbohydrate ligands. Infect Immun 77, 2065-2075.
7. Deptula, A. and Gospodarek, E. (2010) Reduced expression of virulence factors in multi-drug resistant Pseudomonas aeruginosa strains. Arch Microbiol 192, 79-84.
8. Engel, J. and Balachandran, P. (2009) Role of Pseudomonas aeruginosa type III effectors in disease. Cur Opin Microbiol 12, 61-66.
9. European Parliament and Council (2009). Directive 2009/54/EC of European Parliament and of the Council of 18 June 2009 on the exploitation and marketing of natural mineral waters. Off J Eur Union 2009; L164, 26.6.2009, 45-58.
10. Finnan, S., Morrissey, J.P., O'Gara, F. and Boyd, E.F. (2004) Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol 42, 5783-5792.
11. Fricks-Lima, J., Hendrickson, C.M., Allgaier, A., Zhuo, H., Wiener-Kronish, J.P., Lynch, S.V. and Yang, K. (2011) Differences in biofilm formation and antimicrobial resistance of Pseudomonas aeruginosa isolated from airways of mechanically ventilated patients and cystic fibrosis patients. Int J Antimicrob Agents 37, 309-315.
12. Greenacre, M. (2008) Análisis de correspondencias múltiples. In La práctica del análisis de correspondencias ed. Greenacre, M. pp. 185-193. Bilbao: Fundación BBVA.
13. Hauser, A.R. (2009) The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nat Rev Microbiol 7, 654-665.
14. Hubert, B., de Mahenge, C., Peloux, Y., Grimont, P.A.D.F., Richar, C., Fleurette, J., Bacou, J. and Meyer, L. (1988) Epidémie de pneumonies et de méningites dans un établissement thermal: isolement d'une bactérie non antérieurement rencontrée en pathologie humaine. Bulletin Épidémiologique Hebdomadaire 10, 37-38.
15. Kaszab, E., Szoboszlay, S., Dobolyi, C., Háhn, J., Pék, N. and Keist, B. (2010) Antibiotic resistance profiles and virulence markers of Pseudomonas aeruginosa strains isolated from composts. Bioresour Technol 102, 1543-1548.
16. Le Roux, B. and Rouanet, H. (2004) Multiple correspondence analysis. In Geometric Data Analysis: From Correspondence Analysis to Structured data Analysis eds Le Roux, B. and Rouanet, H. pp. 179-241. Dordrecht, The Netherlands: Kluwer Academic Publishers.
17. Leclerc, H. and Moreau, A. (2002) Microbiological safety of natural mineral water. FEMS Microbiol Rev 26, 207-222.
18. Lomholt, J.A., Poulsen, K. and Kilian, M. (2001) Epidemic structure of Pseudomonas aeruginosa: evidence for a clone that is pathogenic to the eye and that has distinct combination of virulence factors. Infect Immun 69, 6284-6295.
19. Ma, L., Conover, M., Lu, H., Parsek, M.R., Bayles, K. and Wozniak, D.J. (2009) Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 5, e1000354.
20. Maslow, J.N., Slutsky, A.M. and Arbeit, R.D. (1993) Application of pulsed-field gel electrophoresis to molecular epidemiology. In Diagnostic Molecular Microbiology eds Persing, D.H., Smith, T.F., Tenover, F.C. and White, T.J. pp. 563-572. Washington: American Society for Microbiology.
21. Miyata, S., Casey, M., Frank, D.W., Ausubel, F.M. and Drenkard, E. (2003) Use of Galleria mellonella caterpillar as a model host to study the role of type III secretion system in Pseudomonas aeruginosa pathogenesis. Infect Immun 71, 2404-2413.
22. Okumura, Y., Matsui, T., Ogawa, K., Uchiya, K. and Nikai, T. (2008) Biochemical properties and primary structure of elastase inhibitor AFUEI from Aspergillus fumigatus. J Med Microbiol 57, 803-808.
23. Pereira, S.G., Paixão, J. and Cardoso, O. (2011) Pseudomonas aeruginosa in a hydropathic facility: diversity, susceptibility and imipenem resistance mutation. Lett Appl Microbiol 53, 518-524.
24. Pierson, L.S. 3rd and Pierson, E.A. (2010) Metabolism and function of phenazines in bacteria: impacts on the behavior of bacteria in the environment and biotechnological processes. Appl Microbiol Biotechnol 86, 1659-1670.
25. Portuguese Spas Association (2013) http://www.termasdeportugal.pt (accessed on 2nd August 2013).
26. Rocha, G., Veríssimo, A., Bowker, R., Bornstein, N. and da Costa, M.S. (1995) Relationship between Legionella spp. and antibody titres at a therapeutic thermal thermae in Portugal. Epidemiol Infect 115, 79-88.
27. Sadikot, R.T., Blackwell, T.S., Christman, J.W. and Prince, A.S. (2005) Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. Am J Respir Crit Care Med 171, 1209-1223.
28. Schilliger, P. and Bardelay, G. (1989) Effects indésirables des cures thermals. In: La cure thermale: savoir evaluer et prescrire. Conseils & arguments ed. Schilliger, P. and Berdelay, G. pp. 131-141. Paris: Editions Frison-Roche.
29. Strateva, T. and Mitov, I. (2011) Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infections. Ann Microbiol 61, 717-732.
30. Vinogradova, Y., Hippisley-Cox, J. and Coupland, C. (2009) Identification of new risk factors for pneumonia: population-based case-control study. Br J Gen Pract 59, e329-e338.